or Try an Advanced Search...

    Technical Analysis for VERA - Vera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 46.39 1.40% 0.64
    VERA closed down 0.33 percent on Wednesday, November 20, 2024, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical VERA trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 1.40%
    NR7 Range Contraction 1.40%
    Inside Day Range Contraction 1.40%
    Bullish Engulfing Bullish 1.07%
    Crossed Above 20 DMA Bullish 1.07%
    Fell Below 20 DMA Bearish 3.53%
    MACD Bearish Signal Line Cross Bearish 3.53%
    Wide Bands Range Expansion 3.53%
    Down 3 Days in a Row Weakness 3.53%
    Wide Bands Range Expansion 0.28%
    Older End-of-Day Signals for VERA ...

       Recent Intraday Alerts

    Alert Time
    Gapped Up (Full) 21 minutes ago
    Rose Above Previous Day's High 29 minutes ago
    Up 3% 29 minutes ago
    Up 2% 29 minutes ago
    Up 1% 29 minutes ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VERA Chart by TradingView
    Basic chart:

    Profile

    Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Health Care

    Is VERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
    Nov 11 Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Nov 11 Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet
    Nov 11 Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study
    Nov 8 Vera Therapeutics to Participate at Upcoming Investor Conferences
    Nov 7 Vera Therapeutics reports Q3 results
    Nov 7 Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
    Oct 30 Vera Therapeutics prices $300M offering at $42 per share
    Oct 30 Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
    Oct 29 Vera Therapeutics price target raised to $64 from $56 at Guggenheim
    See more VERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 51.61
    52 Week Low 12.28
    Average Volume 853,980
    200-Day Moving Average 40.62
    50-Day Moving Average 43.03
    20-Day Moving Average 45.62
    10-Day Moving Average 47.55
    Average True Range 2.71
    RSI (14) 52.38
    ADX 27.08
    +DI 27.30
    -DI 20.63
    Chandelier Exit (Long, 3 ATRs) 43.49
    Chandelier Exit (Short, 3 ATRs) 47.34
    Upper Bollinger Bands 51.82
    Lower Bollinger Band 39.41
    Percent B (%b) 0.51
    BandWidth 27.21
    MACD Line 1.30
    MACD Signal Line 1.59
    MACD Histogram -0.2974
    Fundamentals Value
    Market Cap 2.46 Billion
    Num Shares 53.7 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -16.00
    Price-to-Sales 0.00
    Price-to-Book 16.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 47.99
    Resistance 3 (R3) 47.97 47.22 47.61
    Resistance 2 (R2) 47.22 46.65 47.22 47.49
    Resistance 1 (R1) 46.48 46.30 46.11 46.50 47.36
    Pivot Point 45.73 45.73 45.54 45.73 45.73
    Support 1 (S1) 44.99 45.16 44.62 45.01 44.14
    Support 2 (S2) 44.24 44.81 44.24 44.01
    Support 3 (S3) 43.50 44.24 43.89
    Support 4 (S4) 43.52